Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL.
Lúcio P, Parreira A, van den Beemd MW, van Lochem EG, van Wering ER, Baars E, Porwit-MacDonald A, Bjorklund E, Gaipa G, Biondi A, Orfao A, Janossy G, van Dongen JJ, San Miguel JF. Lúcio P, et al. Among authors: van den beemd mw. Leukemia. 1999 Mar;13(3):419-27. doi: 10.1038/sj.leu.2401279. Leukemia. 1999. PMID: 10086733
BIOMED-1 concerted action report: flow cytometric characterization of CD7+ cell subsets in normal bone marrow as a basis for the diagnosis and follow-up of T cell acute lymphoblastic leukemia (T-ALL).
Porwit-MacDonald A, Björklund E, Lucio P, van Lochem EG, Mazur J, Parreira A, van den Beemd MW, van Wering ER, Baars E, Gaipa G, Biondi A, Ciudad J, van Dongen JJ, San Miguel JF, Orfao A. Porwit-MacDonald A, et al. Among authors: van den beemd mw. Leukemia. 2000 May;14(5):816-25. doi: 10.1038/sj.leu.2401741. Leukemia. 2000. PMID: 10803512
BIOMED-I concerted action report: flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings. BIOMED-1 Concerted Action Investigation of Minimal Residual Disease in Acute Leukemia: International Standardization and Clinical Evaluation.
Lucio P, Gaipa G, van Lochem EG, van Wering ER, Porwit-MacDonald A, Faria T, Bjorklund E, Biondi A, van den Beemd MW, Baars E, Vidriales B, Parreira A, van Dongen JJ, San Miguel JF, Orfao A; BIOMED-I. Lucio P, et al. Among authors: van den beemd mw. Leukemia. 2001 Aug;15(8):1185-92. doi: 10.1038/sj.leu.2402150. Leukemia. 2001. PMID: 11480560
Detection of minimal residual disease in acute leukemia patients.
van Dongen JJ, Szczepański T, de Bruijn MA, van den Beemd MW, de Bruin-Versteeg S, Wijkhuijs JM, Tibbe GJ, van Gastel-Mol EJ, Groeneveld K, Hooijkaas H. van Dongen JJ, et al. Among authors: van den beemd mw. Cytokines Mol Ther. 1996 Jun;2(2):121-33. Cytokines Mol Ther. 1996. PMID: 9384697 Review.
11 results